Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001853283 | SCV002186471 | uncertain significance | Hereditary hemochromatosis | 2021-07-14 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid with valine at codon 222 of the TFR2 protein (p.Glu222Val). The glutamic acid residue is highly conserved and there is a moderate physicochemical difference between glutamic acid and valine. This variant has not been reported in the literature in individuals affected with TFR2-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001833171 | SCV002079946 | uncertain significance | Hemochromatosis type 3 | 2020-12-28 | no assertion criteria provided | clinical testing |